Various studies have shown Bazedoxifene could inhibit tumor growth by targeting the IL-6/GP130/STAT3 signaling pathway (Wu et al., 2016; Xiao et al., 2017; Chen et al., 2019; Ma et al., 2019). This evidence concerns the gene IL6 and neoplasm.